Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | Five-year follow up of the UK CLL Forum ibrutinib data

George Follows, BCh, PhD, FRCP, FRCPath, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, updates us on the UK CLL Forum 5-year follow up data for ibrutinib in R/R chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.